- Investing Ideas
- /
- Healthcare Sector
Healthcare Sector
Results
1940
0 new
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
1,940 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
MCK | US$488.25 | -3.9% | 12.3% | US$62.1b | US$605.28 | PE21.4x | E10.0% | 0.6% | Healthcare | ||
COR | US$224.92 | -1.4% | 25.0% | US$43.9b | US$259.92 | PE23.7x | E11.3% | 0.9% | Healthcare | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
IQV | US$234.79 | -3.0% | 19.3% | US$43.1b | US$276.77 | PE30.1x | E13.2% | 0% | Pharmaceuticals & Biotech | ||
GEHC | US$91.99 | 1.9% | 35.2% | US$42.2b | US$95.44 | PE26.5x | E12.6% | 0.1% | Healthcare | ||
A | US$148.06 | 5.7% | 32.4% | US$42.2b | US$147.51 | PE30.1x | E3.7% | 0.6% | Pharmaceuticals & Biotech | ||
IDXX | US$511.78 | 1.0% | 17.0% | US$41.9b | US$546.33 | PE49.8x | E10.3% | n/a | Healthcare | ||
EW | US$66.58 | -0.4% | -3.9% | US$39.6b | US$78.11 | PE26x | E5.1% | n/a | Healthcare | ||
CNC | US$74.58 | -1.4% | 8.3% | US$38.8b | US$86.19 | PE13.9x | E7.1% | n/a | Healthcare | ||
HUM | US$319.57 | 3.0% | -34.3% | US$37.7b | US$391.10 | PE22.5x | E19.1% | 1.1% | Healthcare | ||
RMD | US$239.00 | -2.4% | 61.6% | US$35.6b | US$217.01 | PE34.4x | E11.4% | 0.9% | Healthcare | ||
ALNY | US$274.91 | 0.4% | 55.2% | US$35.2b | US$285.91 | PS15.1x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
VEEV | US$210.85 | -1.9% | 3.6% | US$33.9b | US$232.89 | PE55.5x | E14.9% | n/a | Healthcare | ||
MTD | US$1,478.92 | 5.2% | 33.5% | US$31.6b | US$1,382.00 | PE39.9x | E8.4% | n/a | Pharmaceuticals & Biotech | ||
BIIB | US$194.67 | -2.4% | -24.3% | US$28.2b | US$271.25 | PE24.5x | E17.0% | n/a | Pharmaceuticals & Biotech | ||
BNTX | US$118.22 | 5.3% | 8.8% | US$28.0b | US$123.93 | PS9.4x | E-5.3% | n/a | Pharmaceuticals & Biotech | ||
DXCM | US$67.29 | -4.5% | -27.9% | US$27.1b | US$96.12 | PE40.4x | E16.5% | n/a | Healthcare | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | Pharmaceuticals & Biotech | ||
CAH | US$109.79 | -1.8% | 26.5% | US$26.4b | US$117.32 | PE31.2x | E12.5% | 1.8% | Healthcare | ||
MRNA | US$65.75 | 0.09% | -36.3% | US$24.6b | US$98.61 | PS5x | E44.0% | n/a | Pharmaceuticals & Biotech | ||
ICLR | US$285.61 | -5.8% | 16.0% | US$23.7b | US$364.50 | PE33.1x | E14.4% | n/a | Pharmaceuticals & Biotech | ||
STE | US$239.05 | 0.9% | 8.9% | US$23.3b | US$246.94 | PE42x | E13.1% | 0.9% | Healthcare | ||
BGNE | US$218.42 | 8.1% | 21.4% | US$22.6b | US$274.14 | PS7.5x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
WST | US$311.00 | 0.9% | -17.1% | US$22.3b | US$351.85 | PE43x | E12.2% | 0.3% | Pharmaceuticals & Biotech |